Researchers conducted a randomized trial that compared the effects of 3 treatment regimens for the prevention of tuberculosis infection among individuals with HIV infection currently taking antiretroviral therapy.
Investigators conducted a study that compared the efficacy of high- vs standard-dose hepatitis B virus revaccination regimens in patients with HIV infection.
Risk for sudden cardiac death increased among people living with HIV with elevated HIV viral load or low CD4 cell counts.
Researchers sough to assess the relationship between CD4/CD8 ratios and the risk for Kaposi sarcoma and non-Hodgkin lymphoma among patients with HIV infection treated with combination antiretroviral therapy.
Researchers sought to assess whether retrospective drug feedback increased adherence to HIV pre-exposure prophylaxis among young women in South Africa and Zimbabwe.
Cancellation is the latest in a string of failures for HIV vaccine research.
Researchers sought to assess the occurrence of macular and microvasculature structure degeneration among patients with active and inactive AIDS-related cytomegalovirus retinitis.
In a secondary data analysis, investigators sought to assess potential prescribing disparities for integrase strand transfer inhibitors in patients with HIV infection.
Younger individuals, African American and Latinx, those with substance use disorders more likely to discontinue PrEP.
Researchers conducted a trial to compare the effects of dolutegravir vs darunavir in combination with either tenofovir or zidovudine as second-line treatment for patients with HIV infection.
Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy.
Investigators conducted a retrospective cohort study to determine the difference in COVID-19 outcomes in patients with HIV infection compared with those without HIV infection.
Researchers conducted a study to compare the clinical characteristics and outcomes of early symptomatic neurosyphilis and ocular syphilis in patients with or without HIV infection.
Investigators performed a genome-wide screening study to determine whether silencing specific genes induces apoptosis of HIV-infected macrophages.
For men who have sex with men (MSM) and transgender women, long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) is superior to tenofovir disoproxil fumarate-emtricitabine (TDF-FTC) for preventing HIV infection.
The outcomes of this review will provide relevant information for healthcare professionals, policy makers, and commissioners about how best to evaluate national PrEP programs.
Researchers sought to determine whether clopidogrel would be preferred over aspirin to reduce cardiovascular risk in patients with HIV.
Investigators conducted a retrospective molecular epidemiologic study to assess transmitted drug resistance in patients recently diagnosed with HIV infection.
Investigators conducted a study to determine whether cytomegalovirus affects epigenetic age and immune dysregulation in healthy older adults who are asymptomatic.
In a randomized controlled trial, researchers compared emtricitabine and tenofovir alafenamide with tenofovir disoproxil fumarate for reducing the risk of HIV infection in high-risk cisgender men and transgender women who have sex with men.